Global Renal Artery Stenosis Treatment Market, By Drug Type (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Diuretic, Beta-blockers, Angiotensin II Receptor Blockers, Blood Thinners, Angiotensin Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, HMG-CoA Reductase Inhibitors), Treatment (Medication, Renal Artery Endarterectomy, Bypass Surgery, Angioplasty, Others), Diagnosis (CT scan, Magnetic resonance angiography (MRA), Doppler Ultrasound, Renal Arteriography, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Indication (Fibromuscular Dysplasia, Atherosclerosis), Symptoms (Hypertension, Edema, Fluid Retention, Fatigue, Nausea, Vomiting, Decreased kidney  functions, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028